1. Dynamics of immune reconstitution and activation markers in HIV+ treatment-naïve patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabine;Funderburg;PLoS One,2013
2. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy;Hunt;J Infect Dis,2003
3. Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment;Tenorio;J Infect Dis,2014
4. Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection;Shive;Vaccine,2018
5. Hepatitis B vaccination in HIV-infected adults: current evidence, recommendations and practical considerations;Kim;Int J STD AIDS,2009